» Articles » PMID: 12937105

Severe and Unrecognised: Pertussis in UK Infants

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 2003 Aug 26
PMID 12937105
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To diagnose pertussis using culture, polymerase chain reaction, and serology, in children admitted to intensive care units (PICUs) and some paediatric wards in London, and in their household contacts to determine the source of infection.

Methods: Infants <5 months old admitted to London PICUs between 1998 and 2000 with respiratory failure, apnoea and/or bradycardia, or acute life threatening episodes (ALTE), and children <15 years admitted to paediatric wards at St Mary's and St George's Hospitals between 1999 and 2000 with lower respiratory tract infection, apnoea, or ALTE were studied.

Results: Sixty seven per cent of eligible children (142/212) were recruited; 23% (33/142) had pertussis, 19.8% (25/126) on the PICU and 50% (8/16) on wards. Two died. Only 4% (6/142) were culture positive. Pertussis was clinically suspected on admission in 28% of infants (7/25) on the PICU and 75% (6/8) on the wards. Infants on PICU with pertussis coughed for longer, had apnoeas and whooped more often, and a higher lymphocyte count than infants without pertussis. Pertussis and respiratory syncytial virus (RSV) co-infection was frequent (11/33, 33%). Pertussis was confirmed in 22/33 (67%) of those who were first to become ill in the family. For 14/33 children the source of infection was a parent; for 9/33 the source of pertussis was an older fully vaccinated child in the household.

Conclusions: Severe pertussis is under diagnosed. An RSV diagnosis does not exclude pertussis. Future changes to the UK vaccination programme should aim to reduce pertussis transmission to young infants by their parents and older siblings.

Citing Articles

Effects of the COVID-19 Pandemic on Brief Resolved Unexplained Events (BRUEs) in Children: A Comparative Analysis of Pre-Pandemic and Pandemic Periods.

Nosetti L, Zaffanello M, Piacentini G, De Bernardi F, Cappelluti C, Sangiorgio C Life (Basel). 2024; 14(3).

PMID: 38541716 PMC: 10971196. DOI: 10.3390/life14030392.


Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 - December....

Merdrignac L, Ait El Belghiti F, Pandolfi E, Acosta L, Fabianova K, Habington A Vaccine. 2024; 42(9):2370-2379.

PMID: 38472070 PMC: 11007387. DOI: 10.1016/j.vaccine.2024.02.090.


Impact of the COVID-19 pandemic on Bordetella pertussis infections in England.

Tessier E, Campbell H, Ribeiro S, Rai Y, Burton S, Roy P BMC Public Health. 2022; 22(1):405.

PMID: 35220973 PMC: 8882439. DOI: 10.1186/s12889-022-12830-9.


Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018.

Merdrignac L, Ait El Belghiti F, Pandolfi E, Jane M, Murphy J, Fabianova K Euro Surveill. 2021; 26(4).

PMID: 33509338 PMC: 7848786. DOI: 10.2807/1560-7917.ES.2021.26.4.1900762.


A data driven clinical algorithm for differential diagnosis of pertussis and other respiratory infections in infants.

Tozzi A, Gesualdo F, Rizzo C, Carloni E, Russo L, Campagna I PLoS One. 2020; 15(7):e0236041.

PMID: 32702054 PMC: 7377414. DOI: 10.1371/journal.pone.0236041.


References
1.
Grimprel E, Baron S, Levy-Bruhl D, Garnier J, Njamkepo E, Guiso N . Influence of vaccination coverage on pertussis transmission in France. Lancet. 1999; 354(9191):1699-700. DOI: 10.1016/S0140-6736(99)01576-7. View

2.
Ranganathan S, Tasker R, Booy R, Habibi P, Nadel S, Britto J . Pertussis is increasing in unimmunized infants: is a change in policy needed?. Arch Dis Child. 1999; 80(3):297-9. PMC: 1717870. DOI: 10.1136/adc.80.3.297. View

3.
de Melker H, Versteegh F, Conyn-Van Spaendonck M, Elvers L, Berbers G, van der Zee A . Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000; 38(2):800-6. PMC: 86208. DOI: 10.1128/JCM.38.2.800-806.2000. View

4.
Van Buynder P, Owen D, Vurdien J, Andrews N, Matthews R, Miller E . Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect. 2000; 123(3):403-11. PMC: 2810773. DOI: 10.1017/s0950268899003052. View

5.
Edmunds W, Brisson M, Melegaro A, Gay N . The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine. 2002; 20(9-10):1316-30. DOI: 10.1016/s0264-410x(01)00473-x. View